Control of disease can be achieved w Ibrutnib High-risk Relapsed Refractory patients will progress

Jose F. Leis, MD, PhD, explains how Control of disease can be achieved with Ibrutnib High-risk Relapsed Refractory patients will progress at Imedex Great Debates 2018.